STATUS OF ANTIBIOTIC USE IN THE TREATMENT OF MULTI-RESISTANT GRAM-NEGATIVE INFECTIONS AT HANOI MEDICAL UNIVERSITY HOSPITAL

Phạm Văn Hùng1,, Trần Hồng Trâm1, Đoàn Hữu Thiển1, Đoàn Hữu Thiển1, Nguyễn Thị Kiều1
1 National Institute For Control of Vaccine and Biologicals, Ministry of Health

Main Article Content

Abstract

Background: Multi-antibiotic resistance is an urgent problem for the global health sector. Objective: Characterization of antibiotic use in the treatment of multi-resistant Gram-negative infections. Materials and methods: A cross-sectional descriptive design, recording the laboratory characteristics of 237 patients in the Department of Emergency Medicine and Endocrinology-Respiratory Medicine of Hanoi Medical University Hospital from January 2021 to December 2021. Results: The mean age of the patients was 73.2 ± 15.8 years old. The average number of hospital days for all patients was 18.3 ± 12.4 days. More than 60% of patients received a combination of 2 antibiotics both before and after the antibiogram. There were 232/237 hospitalized patients receiving initial antibiotic treatment. The concordance with the antibiogram before the antibiogram was 25.0%, and after the antibiogram was 61.6%. Among the patients taking antibiotics, 62.5% had to change after having the antibiogram, and 35.4% did not have to change. Mechanical ventilation, ICU admission, and appropriate antibiotic treatment are factors related to treatment outcome (p<0.05). Conclusion: Antibiotics used in the treatment of multidrug-resistant gram-negative infections are mostly consistent with reference guidelines.

Article Details

References

1. WHO (2016). The second National Antibiotics Awareness Week in Viet Nam highlights the continued high level commitment of the government against antimicrobial resistance (AMR), Ha Noi.
2. Bergmans DC, Bonten MJ, Gaillard CA, et al. Indications for antibiotic use in ICU patients: a one-year prospective surveillance. J Antimicrob Chemother. 1997;39(4):527-535. doi:10.1093/jac/39.4.527
3. Đoàn Mai Phương, (2017), Báo cáo tại hội nghị khoa học toàn quốc về hồi sức cấp cứu và chống độc 2017, truy cập ngày 31/10/2018, .
4. Al-Hasan MN, Wilson JW, Lahr BD, et al. β-Lactam and Fluoroquinolone Combination Antibiotic Therapy for Bacteremia Caused by Gram-Negative Bacilli. Antimicrob Agents Chemother. 2009;53(4):1386-1394. doi:10.1128/AAC.01231-08
5. Sbrana F, Malacarne P, Viaggi B, et al. Carbapenem-Sparing Antibiotic Regimens for Infections Caused by Klebsiella pneumoniae Carbapenemase–Producing K. pneumoniae in Intensive Care Unit. Clin Infect Dis. 2013;56(5):697-700. doi:10.1093/cid/cis969
6. Nguyễn Bửu Huy, Phan Thị Phụng, Nguyễn Mai Hoa, Vũ Đình Hòa và Nguyễn Hoàng Anh (2018 ). Phân tích tình hình sử dụng kháng sinh trên bệnh nhân viêm phổi bệnh viện/viêm phổi thở máy điều trị tại Khoa Hồi sức tích cực, Bệnh viện Đa khoa Thành phố Cần Thơ, Dược Học, số 507, tr.8-13.
7. Đinh Thị Thúy Hà (2021) Phân tích tình hình sử dụng kháng sinh trong điều trị nhiễm khuẩn gram âm đa kháng tại bệnh viện đa khoa Đồng Nai. Tạp chí Y học Việt Nam. Tập 501. Số 1.tr178-182.